Evidence map›Paper›PMID 32042809›Full record

ArticleAnnals of translational medicine2019

Pulmonary lesions associated with sputum culture-positive actinomycetes: report of one case.

Lingwei Wang, Heng Zhang, Di Wu, Mengjie Feng, Peng Yang, Xiaoyi Hu, Pierre Tattevin, Goohyeon Hong, Rongchang Chen, Chen Qiu

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lingwei WangDepartment of Respiratory and Critical Care Medicine, Shenzhen People's Hospital, Shenzhen Institute of Respiratory Diseases, Shenzhen Key Laboratory of Respiratory Diseases, Shenzhen Key Laboratory of Pathogenic Microorganisms and Bacterial Resistance, First Affiliated Hospital of Southern Science and Technology University, Second Clinical Medical College of Jinan University, Shenzhen 518020, China.
Heng ZhangDepartment of Respiratory and Critical Care Medicine, Shenzhen People's Hospital, Shenzhen Institute of Respiratory Diseases, Shenzhen Key Laboratory of Respiratory Diseases, Shenzhen Key Laboratory of Pathogenic Microorganisms and Bacterial Resistance, First Affiliated Hospital of Southern Science and Technology University, Second Clinical Medical College of Jinan University, Shenzhen 518020, China.
Di WuDepartment of Respiratory and Critical Care Medicine, Shenzhen People's Hospital, Shenzhen Institute of Respiratory Diseases, Shenzhen Key Laboratory of Respiratory Diseases, Shenzhen Key Laboratory of Pathogenic Microorganisms and Bacterial Resistance, First Affiliated Hospital of Southern Science and Technology University, Second Clinical Medical College of Jinan University, Shenzhen 518020, China.
Mengjie FengDepartment of Respiratory and Critical Care Medicine, Shenzhen People's Hospital, Shenzhen Institute of Respiratory Diseases, Shenzhen Key Laboratory of Respiratory Diseases, Shenzhen Key Laboratory of Pathogenic Microorganisms and Bacterial Resistance, First Affiliated Hospital of Southern Science and Technology University, Second Clinical Medical College of Jinan University, Shenzhen 518020, China.
Peng YangDepartment of Respiratory and Critical Care Medicine, Shenzhen People's Hospital, Shenzhen Institute of Respiratory Diseases, Shenzhen Key Laboratory of Respiratory Diseases, Shenzhen Key Laboratory of Pathogenic Microorganisms and Bacterial Resistance, First Affiliated Hospital of Southern Science and Technology University, Second Clinical Medical College of Jinan University, Shenzhen 518020, China.
Xiaoyi HuDepartment of Respiratory and Critical Care Medicine, Shenzhen People's Hospital, Shenzhen Institute of Respiratory Diseases, Shenzhen Key Laboratory of Respiratory Diseases, Shenzhen Key Laboratory of Pathogenic Microorganisms and Bacterial Resistance, First Affiliated Hospital of Southern Science and Technology University, Second Clinical Medical College of Jinan University, Shenzhen 518020, China.
Pierre TattevinInfectious Diseases and ICU, Pontchaillou University Hospital, 35033 Rennes cedex, France.
Goohyeon HongDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Dankook University Hospital, Dankook University College of Medicine, Cheonan, Republic of Korea.
Rongchang ChenDepartment of Respiratory and Critical Care Medicine, Shenzhen People's Hospital, Shenzhen Institute of Respiratory Diseases, Shenzhen Key Laboratory of Respiratory Diseases, Shenzhen Key Laboratory of Pathogenic Microorganisms and Bacterial Resistance, First Affiliated Hospital of Southern Science and Technology University, Second Clinical Medical College of Jinan University, Shenzhen 518020, China.
Chen QiuDepartment of Respiratory and Critical Care Medicine, Shenzhen People's Hospital, Shenzhen Institute of Respiratory Diseases, Shenzhen Key Laboratory of Respiratory Diseases, Shenzhen Key Laboratory of Pathogenic Microorganisms and Bacterial Resistance, First Affiliated Hospital of Southern Science and Technology University, Second Clinical Medical College of Jinan University, Shenzhen 518020, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary actinomycosis (PA) is a rare subacute or chronic infectious disease. As simple culture of Actinomyces in BAL, as with sputum, may represent colonization, the diagnosis of PA relies on pathological examination. The preferred treatment is long-term, high-dose penicillin. A 6-12-month-course of antibacterial treatment is the rule in extended PA, although the optimal duration of treatment has not been investigated through randomized trial. In this article, we report a case presented with slowly-progressing pulmonary cavitary lesions. Actinomyces odontolyticus was detected in sputum specimen harvested by tracheoscopy. The clinical diagnosis was PA, which gradually improved with prolonged treatment of penicillin and ornidazole. This is followed by a discussion of diagnosis and treatment, especially in terms of treatment.

Indexed as

anaerobic bacteriaPulmonary actinomycosis (PA)

Identifiers

PMID32042809
PMCPMC6990027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.